ME/CFS research group
About
Organisation:
Working group head:
Location:
Bergen, Norway
Research types:
Basic research, Clinical research
Link
Website
Description
The purpose of the research group is the investigation of possible medical treatments for ME/CFS and biological mechanisms involved in the disease. The research group consists of doctors and scientists, nurses, research technicians, molecular biologists and health and exercise therapists. The group also conducts ongoing laboratory experiments based on a biobank containing blood samples and other biological materials donated by the participants in the clinical trials conducted by the group. The purpose of the experiments is to identify disease mechanisms and biomarkers for ME/CFS. Clinical studies into cell metabolism (The Cell Metabolism group at the University of Bergen) and immunology (Genetics of Autoimmunity research group at Oslo University Hospital) based on the biobank are conducted in collaboration with the ME/CFS research group at Haukeland University Hospital. Description adapted from working group website: see link above.Research projects
5
Research areas
7
Research types
4
Research networks
0
People
4
Research projects
Cyclophosphamide in ME/CFS (CycloME)
Project status:
Completed
Country:
Norway
Principal investigator:
Øystein Fluge
Organisations:
Haukeland University Hospital
Research period:
2015-03
to 2019-12
to 2019-12
Research types:
Clinical research
Research areas:
Immune system dysfunction
Defective Energy Metabolism in ME/CFS
Project status:
Completed
Country:
Norway
Principal investigator:
Øystein Fluge, Olav Mella, Karl Johan Tronstad
Organisations:
Haukeland University Hospital, University of Bergen
Research period:
2017-07
to 2021-02
to 2021-02
Research types:
Basic research
Research areas:
Immune system dysfunction, Nutritional and metabolic system dysfunction
Genetic studies in ME/CFS to investigate the potential involvement of the immune system and reveal biomarker
Project status:
Completed
Country:
Norway
Principal investigator:
Benedicte Alexandra Lie
Organisations:
Haukeland University Hospital, Oslo University Hospital
Research period:
2017-01
to 2021-01
to 2021-01
Research types:
Basic research
Research areas:
Immune system dysfunction, Genetic risk factors
Plasma cell targeting using the anti-CD38 antibody daratumumab in patients with ME/CFS – a randomized, placebo-controlled and double-blind phase II study
Project status:
Ongoing
Country:
Norway
Principal investigator:
Øystein Fluge
Organisations:
Haukeland University Hospital
Research period:
2025-06
to 2026-12
to 2026-12
Research types:
Clinical research
Research areas:
Immune system dysfunction
Treatment with daratumumab injections in moderate to severe ME/CFS
Project status:
Completed
Country:
Norway
Principal investigator:
Øystein Fluge, Olav Mella
Organisations:
Haukeland University Hospital
Research period:
2022-04
to not available
to not available
Research types:
Clinical research
Research areas:
Immune system dysfunction
Contact
ME/CFS Research Foundation
Ballindamm 27, 20095 Hamburg, Germany
Copyright © 2022 ME/CFS Research Foundation
Imprint -
Data privacy statement